首页 | 本学科首页   官方微博 | 高级检索  
   检索      

慢性乙型肝炎的联合抗病毒治疗
引用本文:陈新月,吴亚松.慢性乙型肝炎的联合抗病毒治疗[J].医学与哲学,2008,29(7):13-16.
作者姓名:陈新月  吴亚松
作者单位:首都医科大学附属佑安医院,北京100069
摘    要:抗病毒治疗是控制乙型肝炎病原进而防止肝硬化、肝癌等并发症的重要手段。就目前的抗病毒药物而言,单一药物的疗效不能令人满意,越来越多的研究数据表明联合抗病毒治疗,包括干扰素α和核苷(酸)类似物联合治疗以及两种核苷(酸)类似物联合治疗可以减少耐药发生,提高抗病毒疗效。联合抗病毒治疗可能是控制乙肝的有效策略,值得进一步研究。

关 键 词:乙肝  联合治疗  干扰素  核苷(酸)类似物

Combination Therapy for Chronic Hepatitis B
CHEN Xin-yue,WU Ya-song.Combination Therapy for Chronic Hepatitis B[J].Medicine & Philosophy:Humanistic & Social Medicine Edition,2008,29(7):13-16.
Authors:CHEN Xin-yue  WU Ya-song
Institution:(Capital Medical University Beijing You-an Hospital ,Beijing 100069 ,China)
Abstract:Antiviral therapy play a very important role in controlling HBV infection and preventing the development of complications such as cirrhosis,hepatic carcinoma. But so far available antiviral medicines are con-cerned,monotherapy is not so satisfactory. There are increasing evidences show that combination therapy sucn as interferon alpha (pegylated interferon alpha) plus nucleoside/nucleotide analogue or combined two kinds of nucleoside/nucleotide analogues could decrease risk of drug resistance and improve antiviral effect. Combination therapy might be a good choice for chronic hepatitis B and deserve further study.
Keywords:hepatitis B  combination therapy  interferon  nucleoside/nucleotide analogue
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号